MARLBOROUGH, Mass.--(BUSINESS WIRE)--Hologic, Inc. (Nasdaq: HOLX) announced today that its new Genius™ Digital Diagnostics System is now CE marked in Europe. Genius Digital Diagnostics is the first ...

Through a Combination of Advanced Imaging and Novel Artificial Intelligence, Latest Diagnostic System for Cervical Cancer Screening Can Help More Accurately Detect Disease, Improve Workflow and ...

MARLBOROUGH, Mass.--(BUSINESS WIRE)--Hologic, Inc. (Nasdaq: HOLX) announced today the U.S. launch of the SuperSonic™ MACH 40 ultrasound system, expanding the Company’s suite of ultrasound technologies ...

On Monday, Hologic Inc (NASDAQ:HOLX) agreed to acquire Gynesonics, Inc. for approximately $350 million. Gynesonics is a privately held medical device company that develops minimally invasive solutions ...

Hologic (NASDAQ:HOLX) has received approval from the U.S. Food and Drug Administration (FDA) approval for its new digital cytology system, making it the first FDA-cleared digital cytology platform.

For the second time just this week, an artificial intelligence-powered tool aimed at improving cervical cancer screening is taking center stage. This time around, Hologic is the star of the show. Its ...

Medical technology firm Hologic has been granted clearance from the FDA to market its Genius Digital Diagnostics System, powered by the company's Genius Cervical AI algorithm. The digital cytology ...

New Panther Fusion Gastrointestinal Bacterial and Expanded Bacterial Assays deliver tailored, actionable diagnostic results to support fast and informed patient care A variety of complex factors, ...

Hologic, Inc. HOLX recently announced the addition of improved features to its Brevera Breast Biopsy System with CorLumina Imaging Technology. Notably, the system was launched in 2017 and has been ...

Hologic’s HOLX Genius Digital Diagnostics System has achieved expanded CE marking in the European Union. The development signals a promising step in the company’s innovation pipeline focused on ...